146 related articles for article (PubMed ID: 38576481)
1. Pharmacological inhibition of Src family kinases attenuates hyperuricemic nephropathy.
Xiong C; Deng J; Wang X; Hou Q; Zhuang S
Front Pharmacol; 2024; 15():1352730. PubMed ID: 38576481
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats.
Liu N; Xu L; Shi Y; Fang L; Gu H; Wang H; Ding X; Zhuang S
Oncotarget; 2017 May; 8(20):33807-33826. PubMed ID: 28442634
[TBL] [Abstract][Full Text] [Related]
3. EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.
Liu N; Wang L; Yang T; Xiong C; Xu L; Shi Y; Bao W; Chin YE; Cheng SB; Yan H; Qiu A; Zhuang S
J Am Soc Nephrol; 2015 Nov; 26(11):2716-29. PubMed ID: 25788532
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic Targeting of BET Proteins Attenuates Hyperuricemic Nephropathy in Rats.
Xiong C; Deng J; Wang X; Shao X; Zhou Q; Zou H; Zhuang S
Front Pharmacol; 2021; 12():636154. PubMed ID: 33664670
[TBL] [Abstract][Full Text] [Related]
5. Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling.
Ren Q; Tao S; Guo F; Wang B; Yang L; Ma L; Fu P
Phytomedicine; 2021 Jul; 87():153552. PubMed ID: 33994251
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy.
Shi M; Guo F; Liao D; Huang R; Feng Y; Zeng X; Ma L; Fu P
Eur J Pharmacol; 2020 Nov; 887():173570. PubMed ID: 32949603
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy.
Bao J; Shi Y; Tao M; Liu N; Zhuang S; Yuan W
Clin Sci (Lond); 2018 Nov; 132(21):2299-2322. PubMed ID: 30293967
[TBL] [Abstract][Full Text] [Related]
8. Ethanol extract of Liriodendron chinense (Hemsl.) Sarg barks attenuates hyperuricemic nephropathy by inhibiting renal fibrosis and inflammation in mice.
Pan J; Zhang C; Shi M; Guo F; Liu J; Li L; Ren Q; Tao S; Tang M; Ye H; Ma L; Fu P
J Ethnopharmacol; 2021 Jan; 264():113278. PubMed ID: 32841699
[TBL] [Abstract][Full Text] [Related]
9. Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model.
Wang X; Deng J; Xiong C; Chen H; Zhou Q; Xia Y; Shao X; Zou H
Drug Des Devel Ther; 2020; 14():2221-2233. PubMed ID: 32606592
[TBL] [Abstract][Full Text] [Related]
10. Fufang Zhenzhu Tiaozhi capsule ameliorates hyperuricemic nephropathy by inhibition of PI3K/AKT/NF-κB pathway.
Li MH; Guan J; Chen Z; Mo JX; Wu KR; Hu XG; Lan T; Guo J
J Ethnopharmacol; 2022 Nov; 298():115644. PubMed ID: 35987412
[TBL] [Abstract][Full Text] [Related]
11. Pterostilbene, a bioactive component of blueberries, alleviates renal fibrosis in a severe mouse model of hyperuricemic nephropathy.
Pan J; Shi M; Li L; Liu J; Guo F; Feng Y; Ma L; Fu P
Biomed Pharmacother; 2019 Jan; 109():1802-1808. PubMed ID: 30551434
[TBL] [Abstract][Full Text] [Related]
12. Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy via Suppressing TGFβ/SMAD3 and JAK2/STAT3 Signaling Pathways.
Ren Q; Wang B; Guo F; Huang R; Tan Z; Ma L; Fu P
Front Pharmacol; 2021; 12():792139. PubMed ID: 35153751
[TBL] [Abstract][Full Text] [Related]
13. Febuxostat attenuates ER stress mediated kidney injury in a rat model of hyperuricemic nephropathy.
He L; Fan Y; Xiao W; Chen T; Wen J; Dong Y; Wang Y; Li S; Xue R; Zheng L; He JC; Wang N
Oncotarget; 2017 Dec; 8(67):111295-111308. PubMed ID: 29340054
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic inhibiting STAT3 delays the progression of kidney fibrosis in hyperuricemia-induced chronic kidney disease.
Pan J; Shi M; Guo F; Ma L; Fu P
Life Sci; 2021 Nov; 285():119946. PubMed ID: 34516993
[TBL] [Abstract][Full Text] [Related]
15. Qi-Zhu-Xie-Zhuo-Fang reduces serum uric acid levels and ameliorates renal fibrosis in hyperuricemic nephropathy rats.
Huijuan W; Xiaoxu C; Rui S; Xinghui L; Beibei T; Jianchun M
Biomed Pharmacother; 2017 Jul; 91():358-365. PubMed ID: 28463799
[TBL] [Abstract][Full Text] [Related]
16. The Terminalia chebula Retz extract treats hyperuricemic nephropathy by inhibiting TLR4/MyD88/NF-κB axis.
Liu H; Chen Z; Liu M; Li E; Shen J; Wang J; Liu W; Jin X
J Ethnopharmacol; 2024 Mar; 322():117678. PubMed ID: 38159820
[TBL] [Abstract][Full Text] [Related]
17. Vitamin C alleviates hyperuricemia nephropathy by reducing inflammation and fibrosis.
Li H; Liu X; Lee MH; Li H
J Food Sci; 2021 Jul; 86(7):3265-3276. PubMed ID: 34160066
[TBL] [Abstract][Full Text] [Related]
18. Zishen Qingre Tongluo Formula Improves Renal Fatty Acid Oxidation and Alleviated Fibrosis via the Regulation of the TGF-
Liu P; Wang C; Wang Y; Zhang H; Liu B; Qiu X
Biomed Res Int; 2021; 2021():2793823. PubMed ID: 34938805
[TBL] [Abstract][Full Text] [Related]
19. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway.
Li Y; Zhao Z; Luo J; Jiang Y; Li L; Chen Y; Zhang L; Huang Q; Cao Y; Zhou P; Wu T; Pang J
Phytomedicine; 2021 Jul; 87():153585. PubMed ID: 34044255
[TBL] [Abstract][Full Text] [Related]
20. Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy.
Shi Y; Tao M; Ma X; Hu Y; Huang G; Qiu A; Zhuang S; Liu N
Cell Death Dis; 2020 Jun; 11(6):467. PubMed ID: 32555189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
